Immunologic Factors: all 3,292 studies that test it

Page 14 of 33. Open to participants first (386), then studies with results posted, then the rest; newest registration first within each.

• The Effect of Rituximab on Mobilization With AMD3100 (Plerixafor) Plus G-CSF in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) or Hodgkin Disease (HD)CompletedNCT00444912Phase 2Results posted
• A Study of the Safety of Rituximab in Combination With Other Anti-Rheumatic Drugs in Subjects With Active Rheumatoid ArthritisCompletedNCT00443651Phase 3Results posted
• Lenalidomide in Previously Treated Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaCompletedNCT00439231Phase 2Results posted
• Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin LymphomaCompletedNCT00438880Phase 1/2Results posted
• Alefacept in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma or Peripheral T-Cell Non-Hodgkin's LymphomaCompletedNCT00438802Phase 1Results posted
• Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic LeukemiaCompletedNCT00436904Phase 2Results posted
• Chemotherapy for Participants With LymphomaCompletedNCT00436280Phase 2Results posted
• MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.CompletedNCT00430352Phase 4Results posted
• Rituximab to the Preparative Regimen of Etoposide and Total Body Irradiation in Acute Lymphoblastic LeukemiaCompletedNCT00427791Phase 2Results posted
• Cellular Therapy With Cord Blood CellsCompletedNCT00427557Phase 2Results posted
• Purine Analog-Based Conditioning in Patients With Severe Aplastic AnemiaCompletedNCT00427336Not applicableResults posted
• Donor Stem Cell Transplantation for Congenital ImmunodeficienciesCompletedNCT00426517Early Phase 1Results posted
• Clinical Study to Evaluate the Efficacy and Safety of Octagam 10% in Idiopathic Thrombocytopenic Purpura in AdultsCompletedNCT00426270Phase 3Results posted
• Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaCompletedNCT00425802Phase 2Results posted
• Rituxan in Churg Strauss Syndrome With Renal InvolvementTerminatedNCT00424749Phase 2Results posted
• A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a TNF-Blocker.CompletedNCT00424502Phase 4Results posted
• A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00424047Phase 3Results posted
• Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)CompletedNCT00422799Phase 2Results posted
• A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)CompletedNCT00422383Phase 3Results posted
• A Multicentre, Single-arm, Open-label Safety Study of Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple MyelomaCompletedNCT00420849Phase 3Results posted
• Rituximab in the Treatment of Scleritis and Non-Infectious Orbital InflammationCompletedNCT00415506Phase 1/2Results posted
• VELCADE,Rituximab,Cyclophosphamide and DecadronTerminatedNCT00413959Phase 2Results posted
• A Study of Revlimid in the Treatment of Non-Hodgkin's LymphomaCompletedNCT00413036Phase 2Results posted
• Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell LymphomaCompletedNCT00411086Phase 2Results posted
• Bevacizumab, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Stage II or III Multiple MyelomaCompletedNCT00410605Phase 2Results posted
• A Study of Ocrelizumab Compared to Placebo in Patients With Active Rheumatoid Arthritis Continuing Methotrexate Treatment (STAGE)TerminatedNCT00406419Phase 3Results posted
• A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older.CompletedNCT00405756Phase 3Results posted
• Lenalidomide in Treating Patients With Advanced or Unresectable Kidney CancerCompletedNCT00403169Phase 2Results posted
• Bevacizumab + CHOP-Rituximab in Untreated Mantle Cell LymphomaCompletedNCT00401817Phase 2Results posted
• Comparison of a DTaP-IPV-HB-PRP~T Combined Vaccine to Infanrix™-Hexa, When Administered With Prevnar® in Thai InfantsCompletedNCT00401531Phase 3Results posted
• A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's LymphomasTerminatedNCT00400764Phase 1/2Results posted
• GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate CancerCompletedNCT00400517Phase 2Results posted
• Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)TerminatedNCT00396812Phase 1/2Results posted
• Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like LymphomaCompletedNCT00392990Phase 2Results posted
• Donor Stem Cell Transplant in Treating Patients With Myeloid Cancer or Other DiseaseTerminatedNCT00392782Phase 2Results posted
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's LymphomaCompletedNCT00389818Phase 2Results posted
• A Trial of the Pharmacokinetics, Safety, and Tolerability of Subcutaneous Gamunex® in Primary ImmunodeficiencyCompletedNCT00389324Phase 2Results posted
• Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's LymphomaCompletedNCT00387959Phase 2Results posted
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus ErythematosusTerminatedNCT00381810Phase 3Results posted
• FCR Plus Sargramostim (GM-CSF) as Frontline Therapy for Symptomatic Chronic Lymphocytic LeukemiaCompletedNCT00381004Phase 2Results posted
• Rituximab for Prevention of Chronic GVHDCompletedNCT00379587Phase 1/2Results posted
• Bortezomib, Lenalidomide, and Dexamethasone Combination Therapy for Patients With Relapsed or Relapsed and Refractory Multiple MyelomaCompletedNCT00378209Phase 2Results posted
• Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple MyelomaActive, not recruitingNCT00378105Phase 1/2Results posted
• S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell LymphomaCompletedNCT00376961Phase 2Results posted
• Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHLCompletedNCT00369707Phase 2Results posted
• Phase 2 Study of Rituximab-ABVD in Classical Hodgkin LymphomaCompletedNCT00369681Phase 2Results posted
• Initial Study of Rituximab to Treat Primary Biliary CirrhosisCompletedNCT00364819Phase 1/2Results posted
• Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKICompletedNCT00363649Phase 2Results posted
• Revlimid in Patients With Acute Myelogenous Leukemia and Myelodysplastic SyndromeCompletedNCT00360672Phase 2Results posted
• Lenalidomide for Patients With Myelofibrosis (MF)CompletedNCT00352794Phase 2Results posted
• Lenalidomide in Treating Older Patients With Acute Myeloid LeukemiaCompletedNCT00352365Phase 2Results posted
• Lenalidomide and Azacitidine in Treating Patients With Advanced Myelodysplastic SyndromesCompletedNCT00352001Phase 1/2Results posted
• A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host DiseaseCompletedNCT00350545Not applicableResults posted
• Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate CancerCompletedNCT00348595Phase 1/2Results posted
• Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow TransplantCompletedNCT00343785Phase 2Results posted
• Rituximab and Combination Chemotherapy in Treating Patients With Primary Central Nervous System LymphomaTerminatedNCT00335140Phase 2Results posted
• Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas TransplantationCompletedNCT00331162Phase 4Results posted
• Rituximab to Treat Severe Hemophilia ACompletedNCT00331006Phase 2Results posted
• Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia PatientsCompletedNCT00323557Phase 2Results posted
• Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)CompletedNCT00322556Phase 3Results posted
• Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4Results posted
• Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaCompletedNCT00312845Phase 3Results posted
• Comparison Study of Rituximab Plus Sargramostim to Rituximab Alone for Relapsed Follicular B-cell Lymphoma, a Form of Non-Hodgkin's LymphomaTerminatedNCT00308087Phase 2Results posted
• Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA AlloantibodiesCompletedNCT00307125Phase 2Results posted
• Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia ATerminatedNCT00306670Phase 2/3Results posted
• Natalizumab Re-Initiation of DosingCompletedNCT00306592Phase 3Results posted
• Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood TransplantCompletedNCT00305682Phase 2Results posted
• Allogeneic Bone Marrow Transplantation Using Less Intensive TherapyTerminatedNCT00303719Phase 2Results posted
• Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell LymphomaCompletedNCT00301821Phase 2Results posted
• Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's DiseaseTerminatedNCT00299988Phase 2Results posted
• Study Evaluating Inotuzumab Ozogamicin [CMC-544] Administered In Combination With Rituximab In Subjects With Non-Hodgkin's Lymphoma (NHL)CompletedNCT00299494Phase 1/2Results posted
• A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid ArthritisCompletedNCT00299130Phase 3Results posted
• A Study to Evaluate Rituximab in Combination With Methotrexate in Methotrexate-Naive Patients With Active Rheumatoid ArthritisCompletedNCT00299104Phase 3Results posted
• Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid ArthritisTerminatedNCT00298272Phase 2Results posted
• Natalizumab (Tysabri) Re-Initiation of DosingTerminatedNCT00297232Phase 3Results posted
• Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's LymphomaCompletedNCT00295932Phase 1/2Results posted
• Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell LymphomaCompletedNCT00294632Phase 1/2Results posted
• GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck CancerCompletedNCT00293462Phase 3Results posted
• Rituximab, Fludarabine, Mitoxantrone, Dexamethasone (R-FND) Plus Zevalin for High-Risk Follicular LymphomaCompletedNCT00290511Phase 2Results posted
• Rituximab Plus Beta-Glucan in Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma (SLL)TerminatedNCT00290407Phase 2Results posted
• Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate VaccineCompletedNCT00289783Phase 3Results posted
• Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic DiseaseCompletedNCT00288600Phase 4Results posted
• Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin LymphomaTerminatedNCT00288067Phase 1/2Results posted
• REVLIMID® (Lenalidomide) for Therapy of Radioiodine-Unresponsive Papillary and Follicular Thyroid CarcinomasCompletedNCT00287287Phase 2Results posted
• Rituximab in the Treatment of Patients With Bullous PemphigoidCompletedNCT00286325Phase 1/2Results posted
• A Study to Evaluate the Efficacy and Safety of Rituximab in Subjects With International Society of Nephrology/Renal Pathology Society (ISN/RPS) 2003 Class III or IV Lupus NephritisCompletedNCT00282347Phase 3Results posted
• A Study to Evaluate the Effects of Rituximab on Immune Responses in Subjects With Active Rheumatoid Arthritis Receiving Background MethotrexateCompletedNCT00282308Phase 2Results posted
• Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic LeukemiaCompletedNCT00281918Phase 3Results posted
• Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic CancerTerminatedNCT00281879Phase 2Results posted
• Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic LeukemiaCompletedNCT00280241Phase 2Results posted
• Rituximab in New Onset Type 1 DiabetesCompletedNCT00279305Phase 2Results posted
• Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.CompletedNCT00278954Phase 3Results posted
• Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's LymphomaCompletedNCT00278161Phase 2Results posted
• Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive CrossmatchCompletedNCT00275509Phase 3Results posted
• A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's LymphomaCompletedNCT00269113Phase 3Results posted
• Chemotherapy and HAART to Treat AIDS-related Primary Brain LymphomaCompletedNCT00267865Phase 2Results posted
• Lenalidomide (Revlimid) in Chronic Lymphocytic Leukemia (CLL)CompletedNCT00267059Phase 2Results posted
• A Study of Retreatment With Rituximab in Patients With Rheumatoid Arthritis Receiving Background MethotrexateCompletedNCT00266227Phase 3Results posted
• Chemoradiation in Locally Advanced Pancreatic CancerTerminatedNCT00262951Phase 2Results posted
• Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy InfantsCompletedNCT00262002Phase 2Results posted

← Immunologic Factors overview